[go: up one dir, main page]

Zygmunt et al., 1968 - Google Patents

Cysteine analogs as potential amino acid antagonists in bacteria

Zygmunt et al., 1968

Document ID
938403956481484680
Author
Zygmunt W
Martin T
Publication year
Publication venue
Journal of Medicinal Chemistry

External Links

Snippet

N-ucciyl-i,-evsteiue, B= X-pmpiimyl-l.-c. vstcinc, C= S-benzyl-Ni 10-undeceiioyl)-L-cysteme, I)= L-cysteine hydantoin, and K--L-cystine hydantoin, with L. mesenteroides. This growth inhibition was completely reversed by the addition of 1000 Mg/ml of L-cysteine or L-cystine …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/50—Nitrogen atoms bound to hetero atoms
    • C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring-systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton

Similar Documents

Publication Publication Date Title
DE69734531T2 (en) INFLUENCE OF NITROSATIVE AND OXIDATIVE STRESS FOR THE TREATMENT OF A DISEASE
EP0550006B1 (en) Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
RU2019132396A (en) MITORIBOSCINS: THERAPEUTIC AGENTS BASED ON MITOCHONDRIA TARGETED TO CANCER CELLS, BACTERIA AND PATHOGENIC YEAST
FI76555B (en) FOR EXAMINATION OF THERAPEUTIC ACID THERAPEUTIC ANVAENDBARA 2- (2-BENZYL-3-MERCAPTOPROPIONYLAMINO) -1-ALKANOL OR 2- (2-BENZYL-3-MERCAPTOPROPIONYLAMINO) -4-METHYLTERIO-SMYL
EP0218027B1 (en) Novel guanidinomethylbenzoic acid derivatives
CH678918A5 (en)
US5364881A (en) S-alkyl-isothioureido-amino acids and use thereof
DE2752719C2 (en) Substituted thiazolidine, thiazanoic and related carboxylic acids
Zygmunt et al. Cysteine analogs as potential amino acid antagonists in bacteria
FI93949C (en) Process for the preparation of novel therapeutically useful salt compounds
RU2050156C1 (en) Substance for treatment of inflammatory or allergic diseases
WO2005051978A2 (en) Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
SK176097A3 (en) Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders
US2460139A (en) Alkamine esters of 2-chloro-4-amino benzoic acid
O'sullivan et al. Inhibiting effects of spermidine derivatives on Trypanosoma Cruzz Trypanothione Reductase
FR2948028A1 (en) ASSOCIATION OF A SODIUM-PROTON EXCHANGER INHIBITOR AND A DIHYDRO-1,3,5-TRIAZINE AMINOUS DERIVATIVE
KR100959031B1 (en) Substituted imidazolidine, preparation method thereof and medicament containing substituted imidazolidine
Johnson et al. Inhibition of dopamine. beta.-hydroxylase by 5-phenoxymethyl-2-oxazolidinethiones
Duke et al. Synthesis and biological evaluation of sparsomycin analogs
Melville The chemistry of biotin
Edelson et al. Synthesis and biological activity of some N-(substituted) glutamines
RU2396262C2 (en) N-(2-benzothiazolyl)amide 2-hydroxy-4-oxo-4-(4-chlorophenyl)-2-butenoic acid having antimicrobial and anti-inflammatory activity
RAY et al. COMPOUNDS FOR CANCER RESEARCH. II. 1 FLUORENE-2-CARBOXAMIDINE
SU1685936A1 (en) N-(haloidophenyl)-2-[(benzo-2,1,3-thiadiazol-4-sulphonyl)amino]-5-- chlorobenzamides, showing activity in experimental trichocephaliasis
US4179463A (en) 2-Amino-cyclopent-1-ene-1-dithiocarboxylic acids